Impact of Immunosuppressive Drugs on the Development of Cardiac Allograft Vasculopathy

Publisher： Bentham Science Publishers

E-ISSN： 1875-6212|8|5|706-719

ISSN： 1570-1611

Source： Current Vascular Pharmacology, Vol.8, Iss.5, 2010-09, pp. : 706-719

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Effectiveness of percutaneous coronary intervention in cardiac allograft vasculopathy

By Doshi A.A.   Rogers J.   Kern M.J.   Hauptman P.J.  

The American Journal of Cardiology, Vol. 93, Iss. 1, 2004-01 ,pp. : 90-92

Elsevier

Access to resources Recommend Favorite

Endothelial Dysfunction in Cardiac Allograft Vasculopathy: Potential Pharmacological Interventions

By  

Current Vascular Pharmacology, Vol. 8, Iss. 2, 2010-03 ,pp. : 169-188

Bentham Science Publishers

Access to resources Recommend Favorite

Recent Developments on Coronary Microvasculopathy after Heart Transplantation:A New Target in the Therapy of Cardiac Allograft Vasculopathy

By  

Current Vascular Pharmacology, Vol. 10, Iss. 2, 2012-03 ,pp. : 206-215

Bentham Science Publishers

Access to resources Recommend Favorite

New-Onset Posttransplantation Diabetes Mellitus: Insulin Resistance or Insulinopenia? Impact of Immunosuppressive Drugs, Cytomegalovirus and Hepatitis C Virus Infection

By  

Current Diabetes Reviews, Vol. 1, Iss. 1, 2005-01 ,pp. : 1-10

Bentham Science Publishers

Access to resources Recommend Favorite

Use of rapamycin slows progression of cardiac transplantation vasculopathy

By Mancini D.   Pinney S.   Burkhoff D.  

ACC Current Journal Review, Vol. 12, Iss. 6, 2003-11 ,pp. : 44-44

Elsevier

Access to resources Recommend Favorite